Key result
Updated ISHLT guidelines incorporate new medical therapies and management approaches for pediatric HF.
Why the study?
Pediatric HF causes significant morbidity and mortality, necessitating an update to the 2014 ISHLT guidelines to incorporate interval advancements in medical therapies and new approaches in management.
May inform pediatric HF strategies; leaves open prospective validation of updated interventions.
Pediatric heart failure (HF) secondary to cardiomyopathies, acquired heart disease, and congenital heart disease is associated with significant morbidity and mortality. These guidelines represent an update from the International Society for Heart and Lung Transplantation guidelines for the management of pediatric HF that were published in 2014 and incorporate interval advancements in medical therapies and new approaches in the evaluation and management of children with HF.
No takes yet. Share an insight, caveat, or question.
Irving et al. (2025) conducted a review in Pediatric heart failure. Guidelines for the management of pediatric heart failure was evaluated. The updated ISHLT guidelines incorporate interval advancements in medical therapies and new approaches in the evaluation and management of children with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: